Liver transplantation for patients with intrahepatic cholangiocarcinoma
Adarsh Vijay ∗, Hoonbae Jeon
Division of Hepato-Pancreato-Biliary & Abdominal Transplant Surgery; Tulane Abdominal Transplant Institute, Tulane University School of Medicine, New
Orleans, LA 70112-2632, USA
Abstract：Cholangiocarcinoma (CCA) constitutes a group of heterogeneous malignant tumors emerging in the biliary tree [1]. Based on their anatomical distribution, CCA is classified into perihilar cholangiocarcinoma (pCCA), distal cholangiocarcinoma (dCCA) and intrahepatic cholangiocarcinoma (iCCA) and they account for 60%-70%, 20%-30% and 5%-10% of CCA, respectively. The past decade has seen a 2-fold increase in annual percentage change in incidence of iCCA in USA when compared to the prior three decades [2].
引用本文:
. [J]. Hepatobiliary Pancreat Dis Int, 2022, 21(6): 590-593.
Vijay A, Jeon H. Liver transplantation for patients with intrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int, 2022, 21(6): 590-593.
2022, Vol. 21 
